Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026)
Warby Parker (WRBY) posted Income from Continuing Operations of 3177000.0 for Q1 2026, up 153.39% on a QoQ basis from 5951000.0 in Q4 2025, and down 8.5% year-over-year from 3472000.0 in Q1 2025.
Warby Parker (WRBY) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Warby Parker's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 3177000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 8.5% year-over-year to 3177000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1348000.0 (up 109.45% YoY) and the FY2025 annual result came in at 1643000.0, up 108.05% from the prior year.
- Income from Continuing Operations was 3177000.0 for Q1 2026 at Warby Parker, up from 5951000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5874000.0 in Q3 2025 and bottomed at 34133000.0 in Q1 2022.
- A 5-year average of 11128529.41 and a median of 6902000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 1217.28% — and 2025, when it soared 244.25%.
- Warby Parker's Income from Continuing Operations stood at 20251000.0 in 2022, then increased by 5.95% to 19047000.0 in 2023, then surged by 63.76% to 6902000.0 in 2024, then increased by 13.78% to 5951000.0 in 2025, then surged by 153.39% to 3177000.0 in 2026.
- Business Quant data shows WRBY's Income from Continuing Operations at 3177000.0 in Q1 2026, 5951000.0 in Q4 2025, and 5874000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -5.95 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | -1.75 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | -6.90 Mn |
| Sep 30, 2024 | -4.07 Mn |
| Jun 30, 2024 | -6.76 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | -19.05 Mn |
| Sep 30, 2023 | -17.41 Mn |
| Jun 30, 2023 | -15.93 Mn |
| Mar 31, 2023 | -10.81 Mn |
| Dec 31, 2022 | -20.25 Mn |
| Sep 30, 2022 | -23.84 Mn |
| Jun 30, 2022 | -32.17 Mn |
| Mar 31, 2022 | -34.13 Mn |
| Dec 31, 2021 | -45.90 Mn |
| Sep 30, 2021 | -91.07 Mn |
| Jun 30, 2021 | -10.31 Mn |